Table 3 Association (Odds Ratio (95% CI)) of socio-demographic, seasonal, behavioural, and health-related factors with circadian rhythm clusters in the Whitehall II accelerometer sub-studya
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | Cluster 7 | Cluster 8 | Cluster 9 | |
|---|---|---|---|---|---|---|---|---|---|
RAR ++ PA ++ | RAR + LIPA + Sleep − | RAR + LIPA + Sleep + | MVPA ++ | RAR − Chronotype −− | RAR − PA − Sleep + | RAR − PA − Sleep −− | RAR − PA + Restless sleep | RAR −− PA −− | |
N (%) | 495 (12.5) | 585 (14.7) | 619 (15.6) | 378 (9.5) | 332 (8.4) | 702 (17.7) | 363 (9.1) | 234 (5.9) | 260 (6.6) |
Socio-demographic factors | |||||||||
Age, per 5 years higher age | 0.65 (0.57−0.75)** | 1.04 (0.93−1.17) | Ref | 0.67 (0.58−0.77)** | 0.96 (0.83−1.10) | 1.44 (1.29−1.61)** | 1.48 (1.29−1.69)** | 1.03 (0.89−1.20) | 1.88 (1.61−2.20)** |
Women | 0.74 (0.55−1.00) | 0.68 (0.51−0.90)** | Ref | 0.31 (0.22−0.45)** | 0.51 (0.35−0.72)** | 0.70 (0.52−0.93)* | 0.29 (0.20−0.43)** | 0.39 (0.26−0.59)** | 0.48 (0.32−0.74)** |
Non−white ethnicity | 1.44 (0.75−2.76) | 1.92 (1.12−3.29)* | Ref | 0.72 (0.30−1.73) | 2.52 (1.40−4.51)** | 1.21 (0.71−2.07) | 3.78 (2.19−6.53)** | 4.02 (2.18−7.43)** | 2.76 (1.50−5.06)** |
Lower secondary school or less | 0.95 (0.73−1.23) | 1.25 (0.98−1.59) | Ref | 1.19 (0.90−1.57) | 0.77 (0.57−1.04) | 0.78 (0.61−0.99)* | 0.88 (0.61−1.27) | 1.07 (0.77−1.47) | 1.00 (0.71−1.41) |
Not married/cohabiting | 1.39 (1.01−1.92)* | 1.03 (0.76−1.39) | Ref | 1.89 (1.35−2.63)** | 2.13 (1.53−2.96)** | 1.04 (0.77−1.39) | 1.48 (1.05−2.07)* | 1.62 (1.10−2.39)* | 1.80 (1.23−2.63)** |
In employment | 0.76 (0.55−1.05) | 0.89 (0.66−1.21) | Ref | 1.09 (0.79−1.51) | 0.65 (0.45−0.94)* | 0.92 (0.68−1.24) | 0.88 (0.61−1.27) | 1.59 (1.10−2.31)* | 0.41 (0.23−0.73)** |
Area index of multiple deprivation | |||||||||
Tertile 1 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Tertile 2 | 1.00 (0.74−1.34) | 1.14 (0.87−1.51) | Ref | 0.90 (0.66−1.23) | 0.79 (0.55−1.13) | 0.95 (0.73−1.25) | 0.82 (0.58−1.16) | 1.10 (0.75−1.59) | 1.08 (0.72−1.61) |
Tertile 3 | 1.35 (0.98−1.85) | 1.59 (1.18−2.13)** | Ref | 1.31 (0.94−1.83) | 1.74 (1.23−1.46)** | 1.02 (0.76−1.37) | 1.61 (1.14−1.28)** | 1.50 (1.01−2.22)* | 1.28 (0.84−1.95) |
Behavioural factors | |||||||||
Smoking | |||||||||
Never smokers | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
Ex-smokers | 1.10 (0.86−1.43) | 0.98 (0.78−1.25) | Ref | 1.16 (0.89−1.52) | 1.30 (0.97−1.74) | 0.91 (0.72−1.15) | 0.93 (0.70−1.23) | 1.09 (0.79−1.50) | 1.00 (0.71−1.40) |
Current smokers | 0.54 (0.19−1.49) | 2.44 (1.11−5.34)* | Ref | 0.91 (0.32−2.61) | 5.44 (2.45−12.10)** | 2.67 (1.19−5.95)* | 3.10 (1.28−7.50)* | 0.95 (0.29−3.19) | 8.76 (3.59−21.35)** |
Alcohol consumption | |||||||||
No consumption | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
1−14 units/week | 0.95 (0.66−1.35) | 1.01 (0.73−1.39) | Ref | 1.34 (0.90−2.00) | 0.80 (0.56−1.16) | 0.78 (0.57−1.05) | 0.89 (0.62−1.29) | 0.86 (0.56−1.31) | 0.76 (0.51−1.14) |
> 14 units/week | 1.37 (0.92−2.05) | 1.35 (0.93−1.95) | Ref | 1.55 (0.99−2.41) | 1.00 (0.65−1.53) | 0.83 (0.58−1.20) | 1.09 (0.71−1.67) | 1.35 (0.84−2.17) | 0.58 (0.34−0.97)* |
Fruits and vegetables, <twice a day | 1.19 (0.85−1.66) | 1.15 (0.85−1.56) | Ref | 0.77 (0.53−1.11) | 1.24 (0.88−1.77) | 1.22 (0.90−1.65) | 1.67 (1.20−2.34)** | 1.30 (0.89−1.91) | 1.62 (1.09−2.39)* |
Daily % >1000 lux, 1 SD higher exposure | 1.82 (1.61−2.05)** | 1.05 (0.93−1.18) | Ref | 0.92 (0.79−1.06) | 0.52 (0.44−0.63)** | 0.51 (0.44−0.58)** | 0.48 (0.40−0.57)** | 1.17 (0.998−1.36) | 0.21 (0.16−0.28)** |
Health−related factors | |||||||||
BMI, per 5 kg/m² higher BMI | 0.70 (0.59−0.83)** | 1.39 (1.19−1.62)** | Ref | 0.90 (0.75−1.09) | 1.55 (1.30−1.85)** | 1.73 (1.49−2.00)** | 2.31 (1.95−2.75)** | 1.13 (0.92−1.40) | 2.78 (2.30−3.37)** |
Diabetes | 0.70 (0.43−1.14) | 1.05 (0.72−1.54) | Ref | 0.52 (0.30−0.90)* | 0.90 (0.57−1.42) | 1.37 (0.96−1.96) | 1.23 (0.82−1.85) | 0.71 (0.41−1.23) | 1.32 (0.84−2.06) |
Hypertension | 0.87 (0.67−1.13) | 1.30 (1.01−1.66)* | Ref | 0.95 (0.72−1.25) | 0.77 (0.57−1.03) | 1.27 (0.99−1.62) | 0.95 (0.70−1.29) | 1.07 (0.77−1.49) | 1.26 (0.86−1.86) |
Hyperlipidaemia | 0.87 (0.67−1.13) | 1.03 (0.81−1.31) | Ref | 0.93 (0.71−1.22) | 0.87 (0.65−1.16) | 1.00 (0.79−1.26) | 1.03 (0.77−1.37) | 1.08 (0.79−1.48) | 1.06 (0.76−1.48) |
Prevalence of ≥1 chronic diseasesb | 0.94 (0.72−1.24) | 0.98 (0.76−1.26) | Ref | 0.94 (0.70−1.26) | 1.37 (1.01−1.86)* | 1.04 (0.81−1.33) | 1.11 (0.82−1.49) | 0.87 (0.62−1.23) | 1.53 (1.08−2.18)* |
CNS medication | 0.44 (0.23−0.86)* | 1.10 (0.65−1.85) | Ref | 0.56 (0.27−1.19) | 1.71 (0.98−2.98) | 1.21 (0.73−2.02) | 2.52 (1.45−4.37)** | 2.38 (1.31−4.32)** | 3.57 (2.01−6.33)** |